Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1430

1.

In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse model.

Carreras A, Pane LS, Nitsch R, Madeyski-Bengtson K, Porritt M, Akcakaya P, Taheri-Ghahfarokhi A, Ericson E, Bjursell M, Perez-Alcazar M, Seeliger F, Althage M, Knöll R, Hicks R, Mayr LM, Perkins R, Lindén D, Borén J, Bohlooly-Y M, Maresca M.

BMC Biol. 2019 Jan 15;17(1):4. doi: 10.1186/s12915-018-0624-2.

2.

Metabolic patterns and seizure outcomes following anterior temporal lobectomy.

Cahill V, Sinclair B, Malpas CB, McIntosh AM, Chen Z, Vivash LE, O'Shea MF, Wilson SJ, Desmond PM, Berlangieri SU, Hicks RJ, Rowe CC, Morokoff AP, King JA, Fabinyi GC, Kaye AH, Kwan P, Berkovic SF, O'Brien TJ.

Ann Neurol. 2019 Jan 4. doi: 10.1002/ana.25405. [Epub ahead of print]

PMID:
30609109
3.

PET/CT Lung Ventilation and Perfusion Scanning using Galligas and Gallium-68-MAA.

Le Roux PY, Hicks RJ, Siva S, Hofman MS.

Semin Nucl Med. 2019 Jan;49(1):71-81. doi: 10.1053/j.semnuclmed.2018.10.013. Epub 2018 Nov 17. Review.

PMID:
30545520
4.

Voxel-wise correlation of PET/CT with multiparametric MRI and histology of the prostate using a sophisticated registration framework.

Reynolds HM, Williams S, Jackson P, Mitchell C, Hofman MS, Hicks RJ, Murphy DG, Haworth A.

BJU Int. 2018 Dec 10. doi: 10.1111/bju.14648. [Epub ahead of print]

PMID:
30536698
5.

Consensus on molecular imaging and theranostics in prostate cancer.

Fanti S, Minozzi S, Antoch G, Banks I, Briganti A, Carrio I, Chiti A, Clarke N, Eiber M, De Bono J, Fizazi K, Gillessen S, Gledhill S, Haberkorn U, Herrmann K, Hicks RJ, Lecouvet F, Montironi R, Ost P, O'Sullivan JM, Padhani AR, Schalken JA, Scher HI, Tombal B, van Moorselaar RJA, Van Poppel H, Vargas HA, Walz J, Weber WA, Wester HJ, Oyen WJG.

Lancet Oncol. 2018 Dec;19(12):e696-e708. doi: 10.1016/S1470-2045(18)30604-1. Review.

PMID:
30507436
6.

Evaluation of the bacterial burden of gel nails, standard nail polish, and natural nails on the hands of health care workers.

Hewlett AL, Hohenberger H, Murphy CN, Helget L, Hausmann H, Lyden E, Fey PD, Hicks R.

Am J Infect Control. 2018 Dec;46(12):1356-1359. doi: 10.1016/j.ajic.2018.05.022. Epub 2018 Jul 6.

PMID:
30509357
7.

A Prospective, Multi-site, International Comparison of F-18 fluoro-methyl-choline, multi-parametric magnetic resonance and Ga-68 HBED-CC (PSMA-11) in men with High-Risk Features and Biochemical Failure after Radical Prostatectomy: Clinical Performance and Patient Outcomes.

Emmett L, Metser U, Bauman G, Hicks RJ, Weickhardt A, Davis ID, Punwani S, Pond GR, Chua SS, Ho B, Johnston E, Pouliot F, Scott A.

J Nucl Med. 2018 Nov 15. pii: jnumed.118.220103. doi: 10.2967/jnumed.118.220103. [Epub ahead of print]

PMID:
30442757
8.

First-in-human trial of 64Cu-SARTATE PET imaging of patients with neuroendocrine tumours demonstrates high tumor uptake and retention, potentially allowing prospective dosimetry for peptide receptor radionuclide therapy.

Hicks RJ, Jackson P, Kong G, Ware RE, Hofman MS, Pattison DA, Akhurst T, Drummond E, Roselt P, Callahan J, Price R, Jeffery C, Hong E, Noonan W, Herschtal A, Hicks LJ, Harris M, Hedt A, Paterson BM, Donnelly P.

J Nucl Med. 2018 Nov 15. pii: jnumed.118.217745. doi: 10.2967/jnumed.118.217745. [Epub ahead of print]

PMID:
30442752
9.

Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series.

Mitchell EL, Lau PKH, Khoo C, Liew D, Leung J, Liu B, Rischin A, Frauman AG, Kee D, Smith K, Brady B, Rischin D, Gibson A, Mileshkin L, Klein O, Weickhardt A, Arulananda S, Shackleton M, McArthur G, Östör A, Cebon J, Solomon B, Buchanan RR, Wicks IP, Lo S, Hicks RJ, Sandhu S.

Eur J Cancer. 2018 Dec;105:88-102. doi: 10.1016/j.ejca.2018.09.027. Epub 2018 Nov 13.

PMID:
30439628
10.

Hypophosphatasia: A rare disorder.

Hicks RW, Umnitz L, Seibert DC.

J Am Assoc Nurse Pract. 2018 Nov;30(11):600-602. doi: 10.1097/JXX.0000000000000149.

PMID:
30422875
11.

AN INTERNATIONAL SURVEY ON CLINICAL REPORTING OF DUAL-MODALITY PET/CT IMAGING EXAMINATIONS: A STARTING POINT FOR CROSS-SPECIALTY ENGAGEMENT.

Freudenberg LS, Hicks RJ, Beyer T.

J Nucl Med. 2018 Nov 2. pii: jnumed.118.218073. doi: 10.2967/jnumed.118.218073. [Epub ahead of print]

PMID:
30389815
12.

Diabetic Cardiomyopathy Modelling Using Induced Pluripotent Stem Cell Derived Cardiomyocytes: Recent Advances and Emerging Models.

Granéli C, Hicks R, Brolén G, Synnergren J, Sartipy P.

Stem Cell Rev. 2018 Oct 20. doi: 10.1007/s12015-018-9858-1. [Epub ahead of print] Review.

PMID:
30343468
13.

Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN).

Kong G, Grozinsky-Glasberg S, Hofman MS, Akhurst T, Meirovitz A, Maimon O, Krausz Y, Godefroy J, Michael M, Gross DJ, Hicks RJ.

Eur J Nucl Med Mol Imaging. 2018 Oct 20. doi: 10.1007/s00259-018-4196-8. [Epub ahead of print]

PMID:
30343432
14.

Distal limb pathologic conditions in horses treated with sleeve-style digital cryotherapy (285 cases).

Proctor-Brown L, Hicks R, Colmer S, Guilfoyle D, Dallap-Schaer B, Johnson AL, Tomlinson J.

Res Vet Sci. 2018 Dec;121:12-17. doi: 10.1016/j.rvsc.2018.09.008. Epub 2018 Oct 2.

PMID:
30308395
15.

FDG PET/CT for assessing tumour response to immunotherapy : Report on the EANM symposium on immune modulation and recent review of the literature.

Aide N, Hicks RJ, Le Tourneau C, Lheureux S, Fanti S, Lopci E.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):238-250. doi: 10.1007/s00259-018-4171-4. Epub 2018 Oct 5. Review.

16.

Dosimetry of Lu-177 PSMA-617 in metastatic castration-resistant prostate cancer: correlations between pre-therapeutic imaging and "whole body" tumor dosimetry with treatment outcomes.

Violet JA, Jackson P, Ferdinandus J, Sandhu S, Akhurst T, Iravani A, Kong G, Ravi Kumar A, Thang SP, Eu P, Scalzo M, Murphy D, Williams SG, Hicks RJ, Hofman MS.

J Nucl Med. 2018 Oct 5. pii: jnumed.118.219352. doi: 10.2967/jnumed.118.219352. [Epub ahead of print]

PMID:
30291192
17.

A pilot study of cardiopulmonary exercise testing and cardiac stress positron emission tomography before major non-cardiac surgery.

Ferguson MT, Hofman MS, Ismail H, Melville A, Yap KSK, Hicks RJ, Wright S, Riedel B.

Anaesthesia. 2018 Dec;73(12):1524-1530. doi: 10.1111/anae.14447. Epub 2018 Oct 3.

PMID:
30284241
18.

Utilizing microphysiological systems and induced pluripotent stem cells for disease modeling: a case study for blood brain barrier research in a pharmaceutical setting.

Fabre KM, Delsing L, Hicks R, Colclough N, Crowther DC, Ewart L.

Adv Drug Deliv Rev. 2018 Sep 22. pii: S0169-409X(18)30245-X. doi: 10.1016/j.addr.2018.09.009. [Epub ahead of print] Review.

PMID:
30253201
19.

Access, knowledge and experience with FDG-PET/CT in infection management: a survey of Australia and New Zealand infectious diseases physicians and microbiologists.

Douglas AP, Thursky KA, Worth LJ, Harrison SJ, Hicks RJ, Slavin MA.

Intern Med J. 2018 Sep 19. doi: 10.1111/imj.14117. [Epub ahead of print]

PMID:
30230669
20.

Diagnostic Accuracy of 68Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer.

Hicks RM, Simko JP, Westphalen AC, Nguyen HG, Greene KL, Zhang L, Carroll PR, Hope TA.

Radiology. 2018 Dec;289(3):730-737. doi: 10.1148/radiol.2018180788. Epub 2018 Sep 18.

PMID:
30226456
21.

Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer's Disease.

Cardoso BR, Roberts BR, Malpas CB, Vivash L, Genc S, Saling MM, Desmond P, Steward C, Hicks RJ, Callahan J, Brodtmann A, Collins S, Macfarlane S, Corcoran NM, Hovens CM, Velakoulis D, O'Brien TJ, Hare DJ, Bush AI.

Neurotherapeutics. 2018 Sep 13. doi: 10.1007/s13311-018-0662-z. [Epub ahead of print]

PMID:
30215171
22.

Bayesian approach to determining penetrance of pathogenic SDH variants.

Benn DE, Zhu Y, Andrews KA, Wilding M, Duncan EL, Dwight T, Tothill RW, Burgess J, Crook A, Gill AJ, Hicks RJ, Kim E, Luxford C, Marfan H, Richardson AL, Robinson B, Schlosberg A, Susman R, Tacon L, Trainer A, Tucker K, Maher ER, Field M, Clifton-Bligh RJ.

J Med Genet. 2018 Nov;55(11):729-734. doi: 10.1136/jmedgenet-2018-105427. Epub 2018 Sep 10.

23.

A new model for training in hybrid imaging.

Hicks RJ, Freudenberg L, Beyer T.

Lancet Oncol. 2018 Sep;19(9):1152-1154. doi: 10.1016/S1470-2045(18)30482-0. No abstract available.

PMID:
30191837
24.

Barrier Properties and Transcriptome Expression in Human iPSC-Derived Models of the Blood-Brain Barrier.

Delsing L, Dönnes P, Sánchez J, Clausen M, Voulgaris D, Falk A, Herland A, Brolén G, Zetterberg H, Hicks R, Synnergren J.

Stem Cells. 2018 Dec;36(12):1816-1827. doi: 10.1002/stem.2908. Epub 2018 Nov 5.

PMID:
30171748
25.

[177Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer - Author's reply.

Hofman MS, Violet J, Hicks RJ, Sandhu S.

Lancet Oncol. 2018 Aug;19(8):e373. doi: 10.1016/S1470-2045(18)30534-5. No abstract available.

PMID:
30102223
26.

Annotations: A power tool for writers.

Hicks RW, Roberts MEE.

J Am Assoc Nurse Pract. 2018 Aug;30(8):421-423. doi: 10.1097/JXX.0000000000000092. No abstract available.

PMID:
30085983
27.

Outcome of patients with early-stage follicular lymphoma staged with 18F-Fluorodeoxyglucose (FDG) positron emission tomography (PET) and treated with radiotherapy alone.

Ng SP, Khor R, Bressel M, MacManus M, Seymour JF, Hicks RJ, Wirth A.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):80-86. doi: 10.1007/s00259-018-4112-2. Epub 2018 Aug 7.

PMID:
30083824
28.

Equine mesenchymal stromal cells from different tissue sources display comparable immune-related gene expression profiles in response to interferon gamma (IFN)-γ.

Cassano JM, Fortier LA, Hicks RB, Harman RM, Van de Walle GR.

Vet Immunol Immunopathol. 2018 Aug;202:25-30. doi: 10.1016/j.vetimm.2018.06.008. Epub 2018 Jun 11.

PMID:
30078595
29.

A CRISP(e)R view on kidney organoids allows generation of an induced pluripotent stem cell-derived kidney model for drug discovery.

Boreström C, Jonebring A, Guo J, Palmgren H, Cederblad L, Forslöw A, Svensson A, Söderberg M, Reznichenko A, Nyström J, Patrakka J, Hicks R, Maresca M, Valastro B, Collén A.

Kidney Int. 2018 Dec;94(6):1099-1110. doi: 10.1016/j.kint.2018.05.003. Epub 2018 Jul 31.

30.

Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell Carcinoma.

Fan K, Ritter C, Nghiem P, Blom A, Verhaegen ME, Dlugosz A, Ødum N, Woetmann A, Tothill RW, Hicks RJ, Sand M, Schrama D, Schadendorf D, Ugurel S, Becker JC.

Clin Cancer Res. 2018 Dec 1;24(23):5873-5882. doi: 10.1158/1078-0432.CCR-18-1184. Epub 2018 Jul 30.

PMID:
30061360
31.

Decoding non-random mutational signatures at Cas9 targeted sites.

Taheri-Ghahfarokhi A, Taylor BJM, Nitsch R, Lundin A, Cavallo AL, Madeyski-Bengtson K, Karlsson F, Clausen M, Hicks R, Mayr LM, Bohlooly-Y M, Maresca M.

Nucleic Acids Res. 2018 Sep 19;46(16):8417-8434. doi: 10.1093/nar/gky653.

32.

What FDG-PET response-assessment method best predicts survival after curative-intent chemoradiation in non-small cell lung cancer (NSCLC): EORTC, PERCIST, Peter Mac or Deauville criteria?

Turgeon GA, Iravani A, Akhurst T, Beaulieu A, Callahan JW, Bressel M, Cole AJ, Everitt S, Siva S, Hicks RJ, Ball DL, Mac Manus MP.

J Nucl Med. 2018 Jul 20. pii: jnumed.118.214148. doi: 10.2967/jnumed.118.214148. [Epub ahead of print]

PMID:
30030343
33.

Prenatal, Neonatal, and Early Childhood Features in Congenital Myotonic Dystrophy.

Zapata-Aldana E, Ceballos-Sáenz D, Hicks R, Campbell C.

J Neuromuscul Dis. 2018;5(3):331-340. doi: 10.3233/JND-170277.

PMID:
30010141
34.

Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.

Harausz EP, Garcia-Prats AJ, Law S, Schaaf HS, Kredo T, Seddon JA, Menzies D, Turkova A, Achar J, Amanullah F, Barry P, Becerra M, Chan ED, Chan PC, Ioana Chiotan D, Crossa A, Drobac PC, Fairlie L, Falzon D, Flood J, Gegia M, Hicks RM, Isaakidis P, Kadri SM, Kampmann B, Madhi SA, Marais E, Mariandyshev A, Méndez-Echevarría A, Moore BK, Nargiza P, Ozere I, Padayatchi N, Ur-Rehman S, Rybak N, Santiago-Garcia B, Shah NS, Sharma S, Shim TS, Skrahina A, Soriano-Arandes A, van den Boom M, van der Werf MJ, van der Werf TS, Williams B, Yablokova E, Yim JJ, Furin J, Hesseling AC; Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR-TB.

PLoS Med. 2018 Jul 11;15(7):e1002591. doi: 10.1371/journal.pmed.1002591. eCollection 2018 Jul.

35.

A Few Good Men: It's Not Easy Recruiting Male Hospice Palliative Care Volunteers.

Claxton-Oldfield S, McCaffrey-Noviss W, Hicks R.

Am J Hosp Palliat Care. 2018 Dec;35(12):1532-1539. doi: 10.1177/1049909118785370. Epub 2018 Jul 9.

PMID:
29986593
36.

Deep Learning Renal Segmentation for Fully Automated Radiation Dose Estimation in Unsealed Source Therapy.

Jackson P, Hardcastle N, Dawe N, Kron T, Hofman MS, Hicks RJ.

Front Oncol. 2018 Jun 14;8:215. doi: 10.3389/fonc.2018.00215. eCollection 2018.

37.

FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging.

Douglas AP, Thursky KA, Worth LJ, Drummond E, Hogg A, Hicks RJ, Slavin MA.

Eur J Nucl Med Mol Imaging. 2018 Jun 7. doi: 10.1007/s00259-018-4062-8. [Epub ahead of print]

PMID:
29882160
38.

FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1-Selected Patients With NSCLC.

Spigel DR, Chaft JE, Gettinger S, Chao BH, Dirix L, Schmid P, Chow LQM, Hicks RJ, Leon L, Fredrickson J, Kowanetz M, Sandler A, Funke R, Rizvi NA.

J Thorac Oncol. 2018 Nov;13(11):1733-1742. doi: 10.1016/j.jtho.2018.05.004.

PMID:
29775807
39.

Keywords matter: A critical factor in getting published work discovered.

Pearce PF, Hicks RW, Pierson CA.

J Am Assoc Nurse Pract. 2018 Apr;30(4):179-181. doi: 10.1097/JXX.0000000000000048. No abstract available.

PMID:
29757784
40.

[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study.

Hofman MS, Violet J, Hicks RJ, Ferdinandus J, Thang SP, Akhurst T, Iravani A, Kong G, Ravi Kumar A, Murphy DG, Eu P, Jackson P, Scalzo M, Williams SG, Sandhu S.

Lancet Oncol. 2018 Jun;19(6):825-833. doi: 10.1016/S1470-2045(18)30198-0. Epub 2018 May 8.

PMID:
29752180
41.

Humanizing Miniature Hearts through 4-Flow Cannulation Perfusion Decellularization and Recellularization.

Nguyen DT, O'Hara M, Graneli C, Hicks R, Miliotis T, Nyström AC, Hansson S, Davidsson P, Gan LM, Magnone MC, Althage M, Heydarkhan-Hagvall S.

Sci Rep. 2018 May 10;8(1):7458. doi: 10.1038/s41598-018-25883-x.

42.

NKX6.1 induced pluripotent stem cell reporter lines for isolation and analysis of functionally relevant neuronal and pancreas populations.

Gupta SK, Wesolowska-Andersen A, Ringgaard AK, Jaiswal H, Song L, Hastoy B, Ingvorsen C, Taheri-Ghahfarokhi A, Magnusson B, Maresca M, Jensen RR, Beer NL, Fels JJ, Grunnet LG, Thomas MK, Gloyn AL, Hicks R, McCarthy MI, Hansson M, Honoré C.

Stem Cell Res. 2018 May;29:220-231. doi: 10.1016/j.scr.2018.04.010. Epub 2018 Apr 23.

43.

A First-in-Human Study of 68Ga-Nanocolloid PET/CT Sentinel Lymph Node Imaging in Prostate Cancer Demonstrates Aberrant Lymphatic Drainage Pathways.

Doughton JA, Hofman MS, Eu P, Hicks RJ, Williams S.

J Nucl Med. 2018 Dec;59(12):1837-1842. doi: 10.2967/jnumed.118.209171. Epub 2018 May 4.

PMID:
29728517
44.

A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol.

Hofman MS, Murphy DG, Williams SG, Nzenza T, Herschtal A, Lourenco RA, Bailey DL, Budd R, Hicks RJ, Francis RJ, Lawrentschuk N.

BJU Int. 2018 Nov;122(5):783-793. doi: 10.1111/bju.14374. Epub 2018 Jun 3.

PMID:
29726071
45.

An international survey on hybrid imaging: do technology advances preempt our training and education efforts?

Beyer T, Hicks R, Brun C, Antoch G, Freudenberg LS.

Cancer Imaging. 2018 Apr 26;18(1):15. doi: 10.1186/s40644-018-0148-6.

46.

Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma.

Lewin J, Sayers L, Kee D, Walpole I, Sanelli A, Te Marvelde L, Herschtal A, Spillane J, Gyorki D, Speakman D, Estall V, Donahoe S, Pohl M, Pope K, Chua M, Sandhu S, McArthur GA, McCormack CJ, Henderson M, Hicks RJ, Shackleton M.

Ann Oncol. 2018 Jul 1;29(7):1569-1574. doi: 10.1093/annonc/mdy124.

PMID:
29659679
47.

Follow up results of a prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer.

Ng SP, Tan J, Osbourne G, Williams L, Bressel MAB, Hicks RJ, Lau EWF, Chu J, Ngan SYK, Leong T.

Clin Transl Radiat Oncol. 2017 Mar 7;2:76-82. doi: 10.1016/j.ctro.2017.01.008. eCollection 2017 Feb.

48.

Diagnostic challenges in a patient with an occult insulinoma:68 Ga-DOTA-exendin-4 PET/CT and 68Ga-DOTATATE PET/CT.

Bongetti E, Lee MH, Pattison DA, Hicks RJ, Norris R, Sachithanandan N, MacIsaac RJ.

Clin Case Rep. 2018 Mar 1;6(4):719-722. doi: 10.1002/ccr3.1448. eCollection 2018 Apr.

49.

Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma.

Tam CS, Anderson MA, Pott C, Agarwal R, Handunnetti S, Hicks RJ, Burbury K, Turner G, Di Iulio J, Bressel M, Westerman D, Lade S, Dreyling M, Dawson SJ, Dawson MA, Seymour JF, Roberts AW.

N Engl J Med. 2018 Mar 29;378(13):1211-1223. doi: 10.1056/NEJMoa1715519.

50.

Small molecule inducers of ABCA1 and apoE that act through indirect activation of the LXR pathway.

Fan J, Zhao RQ, Parro C, Zhao W, Chou HY, Robert J, Deeb TZ, Raynoschek C, Barichievy S, Engkvist O, Maresca M, Hicks R, Meuller J, Moss SJ, Brandon NJ, Wood MW, Kulic I, Wellington CL.

J Lipid Res. 2018 May;59(5):830-842. doi: 10.1194/jlr.M081851. Epub 2018 Mar 21.

PMID:
29563219

Supplemental Content

Support Center